Mesocortical neurotensin/dopamine system: is it involved in the pathogenesis of schizophrenia?
Satoh
K
K
Department of Psychiatry, Shiga University of Medical Science, Otsu.
D000818:Animals; D001931:Brain Mapping; D002540:Cerebral Cortex / Q000503:physiopathology*; D004298:Dopamine / Q000502:physiology*; D004743:Enkephalin, Leucine / Q000502:physiology; D005625:Frontal Lobe / Q000503:physiopathology; D013006:Growth Hormone / Q000502:physiology; D006801:Humans; D008251:Macaca; D008297:Male; D009496:Neurotensin / Q000502:physiology*; D012559:Schizophrenia / Q000503:physiopathology*; D012565:Schizophrenic Psychology; D013373:Substance P / Q000502:physiology; D009435:Synaptic Transmission / Q000502:physiology*; D014446:Tyrosine 3-Monooxygenase / Q000502:physiology
D013373:Substance P; D009496:Neurotensin; D004743:Enkephalin, Leucine; D013006:Growth Hormone; D014446:Tyrosine 3-Monooxygenase; D004298:Dopamine